Date: March 20-23, 2023
Location: Sheraton Boston Hotel, Boston, MA - Directions
Event Website: https://genetherapy-conference.com/
Join us for our live presentation!
Silvia Ungari, Upstream Development Senior Scientist at AGC Biologics, will be presenting From Process Development to Achieving High Quality GMP Vectors. We hope you'll join us at this amazing event to explore how we can create safer, more efficacious, and more accessible gene therapies for rare disorders.
Click the link above to get all the details.
REQUEST A MEETING
You can also reach out directly to our experts attending the Symposium
Learn about our cell and gene therapy services
Cell Therapy Production and Manufacturing
AGC Biologics’ cell therapy services support every stage of the product journey, from pre-clinical through commercialization. At our Milan and Longmont facilities, we can work with virtually any cell type – including Human Mesenchymal Stem Cells (hMSCs), Exosomes, CD34+, T-Cells, NK Cells, and more.
Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting.
Learn more about our overall cell therapy offering
Viral Vector Production and Manufacturing
AGC Biologics scientists have two decades of viral vector-based gene therapy expertise and specialize in adeno-associated viral vectors (AAV), lentiviral vectors (LVV), and retroviral vectors (RVV). Our sites in the U.S. and Italy have supported four commercial products.
Our ready-to-use platform capabilities for AAV and LVV programs are built on cell factories and bioreactors using adherent and suspension processes, designed entirely in-house.
Discover more about our viral vector services
Plasmid DNA (pDNA) Materials
To support your pDNA needs, AGC Biologics utilizes a customized process based on your specific plasmid and hosting system. We have extensive technical expertise in fermentation, purification, and analytics, and our highly experienced teams routinely manufacture GMP-grade pDNA materials. This work includes starting material for gene therapy, and viral vector manufacturing.
Learn more about our Plasmid offering
Fill out the form below to request a meeting during the event
